[Nonspecific hemostatic therapy for dysfunctional uterine hemorrhages in patients with mild forms of von Willebrand's disease].
Main coagulation parameters against a background of nonspecific haemostatic therapy use (NHT) in women with mild forms of von Willebrand's disease have positive dynamics with coagulation test indices normalized on 5-6 and 10-14 days. Menses length under NHT use is significantly shorter and amounts 6-7 days in 19 (79,2%) patients, 8 days--in 5 (20,8%) women compared to 11-14 days in women without NHT.
V V
VV
Tomilin
D000328:Adult; D000933:Antifibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001777:Blood Coagulation / Q000187:drug effects; D005260:Female; D006801:Humans; D008595:Menorrhagia / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D008875:Middle Aged; D010974:Platelet Aggregation / Q000187:drug effects; D012720:Severity of Illness Index; D013997:Time Factors; D016896:Treatment Outcome; D055815:Young Adult; D014842:von Willebrand Diseases / Q000097:blood / Q000150:complications / Q000188:drug therapy*
D000933:Antifibrinolytic Agents